GT Biopharma News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

13.08.21	GT Biopharma Provides Second Quarter 2021 Business Update (PR Newswire)
13.08.21	GT Biopharma Provides Second Quarter 2021 Business Update (PR Newswire)
06.08.21	GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results (PR Newswire)
06.08.21	GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results (PR Newswire)
03.08.21	GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™ (PR Newswire)
03.08.21	GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™ (PR Newswire)
28.07.21	GT Biopharma Announces $16 million in Warrant Exercise Proceeds (PR Newswire)
28.07.21	GT Biopharma Announces $16 million in Warrant Exercise Proceeds (PR Newswire)
07.07.21	GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota (PR Newswire)
07.07.21	GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota (PR Newswire)
24.06.21	GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa's Global Family Office Investment Summit (PR Newswire)
23.06.21	GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference (PR Newswire)
21.06.21	Dr. Jeffrey S. Miller to Present on Progress of GTB-3550 TriKE™ Phase I Trial Accompanying GT Biopharma's Company Presentation at Raymond James Human Health Innovation Conference (PR Newswire)
16.06.21	GT Biopharma to Present at Raymond James Human Health Innovation Conference (PR Newswire)
08.06.21	GT Biopharma to be Added to the Russell 2000® Index (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V